Skip to main content
Veterinary Medicines

Clavubactin 250/62.5 mg tablet

Not authorised
  • Clavulanic acid
  • Amoxicillin

Product identification

Medicine name:
Clavubactin 250/62.5 mg tablet
Clavubactin 250/62,5 mg comprimidos para cães
Active substance:
  • Clavulanic acid
  • Amoxicillin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clavulanic acid
    62.50
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin
    250.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:
  • Cardboard box containing 10 separate cardboard boxes, each containing 5 Aluminium/aluminium strips with 2 tablets each.
  • Aluminium/aluminium strips with 4 tablets, in a cardboard box containing 50 strips.
  • Aluminium/aluminium strips with 4 tablets, in a cardboard box containing 5 strips.
  • Aluminium/aluminium strips with 4 tablets, in a cardboard box containing 25 strips.
  • Aluminium/aluminium strips with 2 tablets, in a cardboard box containing 5 strips.
  • Aluminium/aluminium strips with 10 tablets, in a cardboard box containing 25 strips.
  • Aluminium/aluminium strips with 10 tablets, in a cardboard box containing 10 strips.
  • Aluminium/aluminium strips with 10 tablets, in a cardboard box containing 1 strip.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • Pharmachem Consulting ApS
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 51480
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0110/002

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 11/10/2022